PNTG - Latest News
The Pennant Group, Inc. (PNTG), operates in Healthcare / Medical - Care Facilities, trades on NASDAQ.
Market capitalization stands near $1.24B. Trailing twelve-month P/E ratio is 40.76. Beta to the broader market is 1.28.
The article list below shows the most recent PNTG headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent PNTG Headlines
The Pennant Group Q1 Earnings Call Highlights
marketbeat.com - May 8, 2026
The Pennant Group NASDAQ: PNTG reported a sharp increase in first-quarter 2026 revenue and adjusted earnings as growth in its home health and hospice
The Pennant Group, Inc. (PNTG) Q1 2026 Earnings Call Transcript
seekingalpha.com - May 7, 2026
The Pennant Group, Inc.
The Pennant Group, Inc. (PNTG) Q1 Earnings and Revenues Surpass Estimates
zacks.com - May 6, 2026
The Pennant Group, Inc. (PNTG) came out with quarterly earnings of $0.
Pennant Reports First Quarter 2026 Results
globenewswire.com - May 6, 2026
EAGLE, Idaho, May 06, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home hea
Pennant Announces First Quarter 2026 Earnings Release and Call
globenewswire.com - May 4, 2026
EAGLE, Idaho, May 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home
How News Affects PNTG Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track PNTG's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked PNTG news questions
- What is the latest PNTG news headline?
- The most recent PNTG headline (May 8, 2026) is "The Pennant Group Q1 Earnings Call Highlights". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the PNTG news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What PNTG news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual PNTG options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.